Windlas Biotech Limited (WINDLAS) — Cash Flow Quality Index
Windlas Biotech Limited (WINDLAS) has a Cash Flow Quality Index of 0.45x as of December 2023. Operating cash flow of Rs67.78 Million is below net income of Rs150.98 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore WINDLAS operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Windlas Biotech Limited Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Windlas Biotech Limited across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Windlas Biotech Limited total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Windlas Biotech Limited (2018–2025)
Year-by-year earnings quality comparison for Windlas Biotech Limited. For live market cap and the full company financial profile, see Windlas Biotech Limited stock valuation.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.12x | Rs681.87 Million | Rs609.94 Million | ▼ -40.3% |
| 2024 | 1.87x | Rs1.09 Billion | Rs581.87 Million | ▲ +75.2% |
| 2023 | 1.07x | Rs609.65 Million | Rs570.39 Million | ▲ +433.4% |
| 2022 | 0.20x | Rs91.30 Million | Rs455.65 Million | ▼ -62.0% |
| 2021 | 0.53x | Rs114.54 Million | Rs217.40 Million | ▼ -48.0% |
| 2020 | 1.01x | Rs250.06 Million | Rs246.68 Million | ▲ +313.6% |
| 2019 | 0.25x | Rs186.54 Million | Rs761.15 Million | ▼ -90.7% |
| 2018 | 2.64x | Rs295.91 Million | Rs111.98 Million | — |